Showing results (221-230 of 250) with videos related to

Sort By:
Pageof 25
European Addiction Research|June 22, 2020
Attention Deficit Hyperactivity Disorder Increases Nicotine Addiction Severity in Adults Seeking Treatment for Substance Use Disorders: The Role of Personality DisordersNatalie C Sánchez-García, Rafael A González, Josep A Ramos-Quiroga, et al.
JAMA Network Open|May 30, 2025
Initiating Injectable Buprenorphine in People Hospitalized With Infections: A Randomized Clinical TrialNikhil Seval, Prerana Roth, Cynthia A Frank, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 6, 2025
Developing a collaborative network for cystic fibrosis in Africa: A call to actionLeah Ratner, Hugues Abriel, Muriel Helmers, et al.
BMJ Open|November 27, 2025
Study protocol for a randomised controlled trial to determine the efficacy of lisdexamfetamine for the treatment of acute methamphetamine withdrawal in inpatient settingsLiam S Acheson, Krista J Siefried, Nicholas Lintzeris, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|September 15, 2025
Attention-deficit/hyperactivity disorder (ADHD) in adults: evidence base, uncertainties and controversiesSamuele Cortese, Mark A Bellgrove, Isabell Brikell, et al.
Contemporary Clinical Trials|September 3, 2014
Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials NetworkErin A McClure, Susan C Sonne, Theresa Winhusen, et al.
The International Journal of Social Psychiatry|June 13, 2025
Religiousness and self-control in patients with substance use disorder (SUD) and comorbid attention deficit/hyperactivity disorder (ADHD)Alex Ha Begeman, Arnt Schellekens, Wim van den Brink, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 7, 2026
Predictors of treatment success in patients with substance use disorder (SUD) and co-morbid attention deficit/hyperactivity disorder (ADHD): Results from the International Naturalistic Cohort Study of ADHD and SUD (INCAS)Christoffer Brynte, Arnt Schellekens, Maija Konstenius, et al.
The Journal of Clinical Psychiatry|December 26, 2024
Treatments and Treatment Predictors in Patients With Substance Use Disorders and Comorbid Attention-Deficit/Hyperactivity Disorder: First Results From the International Naturalistic Cohort Study of ADHD and SUD (INCAS)Christoffer Brynte, Arnt Schellekens, Csaba Barta, et al.
Drug and Alcohol Dependence|June 18, 2017
A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adultsKevin M Gray, Susan C Sonne, Erin A McClure, et al.
Pageof 25